MoneyWorks4Me

Vasundhara Rasayans - Quaterly Results

11 Feb 2026 Evaluate
A decrease in the sales to Rs. 74.48 millions was observed for the quarter ended December 2025. The sales stood at Rs. 88.22 millions during the similar quarter previous year.Net profit of the cmpany stood at Rs. 7.21 millions for the quarter ended December 2025 a decline of -50.38% from Rs. 14.53 millions  in the same quarter last year.The company reported a degrowth in operating Profit to 11.83 millions from 21.09 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 74.48 88.22 -15.57 238.30 262.35 -9.17 339.90 370.18 -8.18
Other Income 6.70 5.40 24.07 22.14 15.19 45.75 23.51 19.41 21.12
PBIDT 11.83 21.09 -43.91 51.75 55.57 -6.87 63.93 83.33 -23.28
Interest 1.00 0.57 75.44 3.28 1.89 73.54 2.69 1.74 54.60
PBDT 10.83 20.52 -47.22 48.47 53.68 -9.71 61.24 81.59 -24.94
Depreciation 1.09 0.88 23.86 3.19 2.59 23.17 3.57 2.64 35.23
PBT 9.74 19.64 -50.41 45.28 51.09 -11.37 57.67 78.95 -26.95
TAX 2.53 5.11 -50.49 11.77 13.29 -11.44 15.21 20.36 -25.29
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.48 -97.92
PAT 7.21 14.53 -50.38 33.51 37.80 -11.35 42.46 58.59 -27.53
Equity 31.78 31.78 0.00 31.78 31.78 0.00 31.78 31.78 0.00
PBIDTM(%) 15.88 23.91 -33.56 21.72 21.18 2.52 18.81 22.51 -16.45
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..